Journal article · 2026 · Open access

Immune dysregulation in prolonged Long-COVID: lymphocytes emerge as key mediators of persistent inflammation, exhaustion and cytotoxicity

Marta Līva Spriņģe, Kristīne Vaivode, Rihards Saksis, Nineļa Miriama Vainšeļbauma, Laura Ansone, Monta Brīvība, Helvijs Niedra, Vita Rovīte

Journal of Translational Medicine, 24(1) · Published 11 April 2026 · DOI 10.1186/s12967-026-08081-6

Open PDFView at the publisherCite this paper

In brief

“Immune dysregulation in prolonged Long-COVID: lymphocytes emerge as key mediators of persistent inflammation, exhaustion and cytotoxicity” is a 2026 journal article by Marta Līva Spriņģe and 7 co-authors, published in Journal of Translational Medicine. OpenAlex counts 8 citations as of 18 November 2026. It is open access under a CC BY licence: the full text is free to read at Journal of Translational Medicine.

Citations
8
Most cited in
2026 (7)
Field-weighted impact
21.13
References
69
Authors
8

Abstract

BACKGROUND: Long-COVID affects at least 10% of COVID-19 survivors, displaying debilitating symptoms across multiple organ systems. Despite the widespread prevalence, Long-COVID aetiology remains poorly understood, but emerging evidence points to immune dysregulation as a potential mechanism involved in its development or persistence. METHODS: This study presents a unique analysis of the peripheral blood mononuclear cell transcriptomic profile of COVID-19 and Long-COVID patients at single-cell resolution. We reconstructed the cell state and intercellular communication using differentially expressed gene profiling and ligand-receptor interaction analyses. RESULTS: Our results reveal altered T and natural killer cell subset proportions, diminished proliferating lymphocyte and B cell signalling capacity, and the expression of exhaustion and cytotoxicity associated genes 1.5-2 years post-infection, suggesting incomplete immune recovery. Distinct interferon responses in these cell populations at the acute phase for patients who go on to develop Long-COVID indicate early disease mediator potential. CONCLUSIONS: Collectively, these findings provide insight into the immune processes underlying the progression of COVID-19 into a chronic Long-COVID state. The observed changes in immune cell subsets at the acute phase of the infection may be predictive of Long-COVID progression and could be useful in understanding disease aetiology while the observed long-term effects are crucial to developing therapeutic and diagnostic tools.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Spriņģe, M. L., Vaivode, K., Saksis, R., Vainšeļbauma, N. M., Ansone, L., Brīvība, M., Niedra, H., & Rovīte, V. (2026). Immune dysregulation in prolonged Long-COVID: lymphocytes emerge as key mediators of persistent inflammation, exhaustion and cytotoxicity. Journal of Translational Medicine, 24(1). https://doi.org/10.1186/s12967-026-08081-6

MLA 9

Spriņģe, Marta Līva, et al. “Immune dysregulation in prolonged Long-COVID: lymphocytes emerge as key mediators of persistent inflammation, exhaustion and cytotoxicity.” Journal of Translational Medicine, vol. 24, no. 1, 2026. https://doi.org/10.1186/s12967-026-08081-6.

Chicago

Spriņģe, Marta Līva, Kristīne Vaivode, Rihards Saksis, Nineļa Miriama Vainšeļbauma, Laura Ansone, Monta Brīvība, Helvijs Niedra, and Vita Rovīte. 2026. “Immune dysregulation in prolonged Long-COVID: lymphocytes emerge as key mediators of persistent inflammation, exhaustion and cytotoxicity.” Journal of Translational Medicine 24 (1). https://doi.org/10.1186/s12967-026-08081-6.

Harvard

Spriņģe, M. L. et al. (2026) ‘Immune dysregulation in prolonged Long-COVID: lymphocytes emerge as key mediators of persistent inflammation, exhaustion and cytotoxicity’, Journal of Translational Medicine, 24(1). doi:10.1186/s12967-026-08081-6.

IEEE

M. L. Spriņģe et al., “Immune dysregulation in prolonged Long-COVID: lymphocytes emerge as key mediators of persistent inflammation, exhaustion and cytotoxicity,” Journal of Translational Medicine, vol. 24, no. 1, 2026, doi: 10.1186/s12967-026-08081-6.

BibTeX

@article{springe2026immune,
  title     = {{Immune dysregulation in prolonged Long-COVID: lymphocytes emerge as key mediators of persistent inflammation, exhaustion and cytotoxicity}},
  author    = {Spriņģe, Marta Līva and Vaivode, Kristīne and Saksis, Rihards and Vainšeļbauma, Nineļa Miriama and Ansone, Laura and Brīvība, Monta and Niedra, Helvijs and Rovīte, Vita},
  journal   = {Journal of Translational Medicine},
  year      = {2026},
  volume    = {24},
  number    = {1},
  doi       = {10.1186/s12967-026-08081-6},
  url       = {https://doi.org/10.1186/s12967-026-08081-6}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Medicine › Clinical Neurology › Long-Term Effects of COVID-19

  • long COVID
  • immune dysregulation
  • chronic inflammation
  • T cell exhaustion
  • natural killer cells
  • lymphocyte cytotoxicity
  • peripheral blood mononuclear cells
  • single-cell transcriptomics

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Spriņģe, M. L., Vaivode, K., Saksis, R., Vainšeļbauma, N. M., Ansone, L., Brīvība, M., Niedra, H., & Rovīte, V. (2026). Immune dysregulation in prolonged Long-COVID: lymphocytes emerge as key mediators of persistent inflammation, exhaustion and cytotoxicity. Journal of Translational Medicine, 24(1). https://doi.org/10.1186/s12967-026-08081-6

How many times has this paper been cited?

8 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Journal of Translational Medicine: sign in and open the PDF from this page.

Who wrote this paper?

Marta Līva Spriņģe, Kristīne Vaivode, Rihards Saksis, Nineļa Miriama Vainšeļbauma, Laura Ansone, Monta Brīvība, Helvijs Niedra, Vita Rovīte.

What is the DOI of this paper?

10.1186/s12967-026-08081-6, permanently at https://doi.org/10.1186/s12967-026-08081-6. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.